Nasdaq Valuation
Is NDAQ * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NDAQ * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NDAQ * (MX$1042.53) is trading above our estimate of fair value (MX$498.31)
Significantly Below Fair Value: NDAQ * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NDAQ *?
Other financial metrics that can be useful for relative valuation.
What is NDAQ *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$33.78b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.1x |
Enterprise Value/EBITDA | 19.4x |
PEG Ratio | 2.4x |
Price to Earnings Ratio vs Peers
How does NDAQ *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 24.3x | ||
BOLSA A Bolsa Mexicana de Valores. de | 12.1x | 6.9% | Mex$18.0b |
300059 East Money InformationLtd | 24x | 10.4% | CN¥194.8b |
388 Hong Kong Exchanges and Clearing | 28.5x | 8.5% | HK$325.7b |
MSCI MSCI | 32.7x | 7.7% | US$38.4b |
NDAQ * Nasdaq | 34.1x | 14.1% | Mex$33.8b |
Price-To-Earnings vs Peers: NDAQ * is expensive based on its Price-To-Earnings Ratio (34.1x) compared to the peer average (24.3x).
Price to Earnings Ratio vs Industry
How does NDAQ *'s PE Ratio compare vs other companies in the South American Capital Markets Industry?
Price-To-Earnings vs Industry: NDAQ * is expensive based on its Price-To-Earnings Ratio (34.1x) compared to the South American Capital Markets industry average (10.5x).
Price to Earnings Ratio vs Fair Ratio
What is NDAQ *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 34.1x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate NDAQ *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$1,042.53 | Mex$1,118.88 +7.3% | 11.6% | Mex$1,344.00 | Mex$840.00 | n/a | 15 |
Jun ’25 | n/a | Mex$1,118.88 0% | 11.6% | Mex$1,344.00 | Mex$840.00 | n/a | 15 |
May ’25 | n/a | Mex$1,147.00 0% | 11.9% | Mex$1,361.42 | Mex$850.89 | n/a | 15 |
Apr ’25 | Mex$1,017.29 | Mex$1,064.42 +4.6% | 12.1% | Mex$1,363.78 | Mex$898.10 | n/a | 15 |
Mar ’25 | Mex$971.31 | Mex$1,058.25 +9.0% | 12.2% | Mex$1,396.80 | Mex$919.85 | n/a | 16 |
Feb ’25 | Mex$1,005.00 | Mex$1,055.09 +5.0% | 12.4% | Mex$1,401.09 | Mex$922.67 | n/a | 16 |
Jan ’25 | Mex$979.85 | Mex$1,022.56 +4.4% | 13.3% | Mex$1,407.77 | Mex$858.40 | n/a | 16 |
Dec ’24 | Mex$963.40 | Mex$1,021.07 +6.0% | 13.2% | Mex$1,410.15 | Mex$859.85 | n/a | 16 |
Nov ’24 | n/a | Mex$1,089.69 0% | 14.0% | Mex$1,499.96 | Mex$914.61 | n/a | 14 |
Oct ’24 | Mex$857.20 | Mex$1,041.88 +21.5% | 14.2% | Mex$1,437.60 | Mex$876.59 | n/a | 14 |
Sep ’24 | Mex$888.00 | Mex$1,025.16 +15.4% | 14.4% | Mex$1,404.66 | Mex$856.50 | n/a | 13 |
Aug ’24 | Mex$862.00 | Mex$999.22 +15.9% | 14.5% | Mex$1,370.87 | Mex$835.90 | n/a | 13 |
Jul ’24 | n/a | Mex$1,047.73 0% | 13.9% | Mex$1,400.77 | Mex$871.21 | n/a | 12 |
Jun ’24 | Mex$967.08 | Mex$1,098.79 +13.6% | 11.6% | Mex$1,451.57 | Mex$938.21 | n/a | 14 |
May ’24 | Mex$1,028.00 | Mex$1,122.05 +9.1% | 11.7% | Mex$1,484.00 | Mex$959.17 | n/a | 14 |
Apr ’24 | n/a | Mex$1,151.91 0% | 11.9% | Mex$1,494.56 | Mex$911.32 | Mex$1,017.29 | 15 |
Mar ’24 | n/a | Mex$1,161.32 0% | 11.7% | Mex$1,505.18 | Mex$917.80 | Mex$971.31 | 15 |
Feb ’24 | Mex$1,097.21 | Mex$1,184.96 +8.0% | 11.8% | Mex$1,539.07 | Mex$938.46 | Mex$1,005.00 | 15 |
Jan ’24 | Mex$1,191.53 | Mex$1,307.59 +9.7% | 12.2% | Mex$1,663.65 | Mex$1,089.29 | Mex$979.85 | 15 |
Dec ’23 | Mex$1,299.00 | Mex$1,272.59 -2.0% | 11.9% | Mex$1,625.69 | Mex$1,064.44 | Mex$963.40 | 15 |
Nov ’23 | Mex$1,191.91 | Mex$1,295.89 +8.7% | 12.3% | Mex$1,684.49 | Mex$1,002.67 | n/a | 15 |
Oct ’23 | n/a | Mex$1,301.77 0% | 11.8% | Mex$1,617.79 | Mex$966.65 | Mex$857.20 | 13 |
Sep ’23 | n/a | Mex$1,305.02 0% | 11.6% | Mex$1,617.99 | Mex$993.62 | Mex$888.00 | 13 |
Aug ’23 | n/a | Mex$1,296.90 0% | 9.5% | Mex$1,515.64 | Mex$1,019.61 | Mex$862.00 | 12 |
Jul ’23 | n/a | Mex$1,340.02 0% | 14.0% | Mex$1,677.42 | Mex$972.90 | n/a | 14 |
Jun ’23 | n/a | Mex$1,339.46 0% | 12.3% | Mex$1,659.93 | Mex$1,069.00 | Mex$967.08 | 15 |
Analyst Forecast: Target price is less than 20% higher than the current share price.